OpenURL Connection Search

Select item for more details and to access through your institution.

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Published in:
Gene Therapy, 2007, v. 14, n. 9, p. 752, doi. 10.1038/sj.gt.3302920
By:
- Golzio, M.;
- Mazzolini, L.;
- Ledoux, A.;
- Paganin, A.;
- Izard, M.;
- Hellaudais, L.;
- Bieth, A.;
- Pillaire, M. J.;
- Cazaux, C.;
- Hoffmann, J. S.;
- Couderc, B.;
- Teissié, J.
Publication type:
Article
Lens cell targetting for gene therapy of prevention of posterior capsule opacification.
Published in:
Gene Therapy, 2006, v. 13, n. 19, p. 1422, doi. 10.1038/sj.gt.3302790
By:
- Malecaze, F.;
- Lubsen, N. H.;
- Serre, B.;
- Decha, A.;
- Duboue, M.;
- Penary, M.;
- Berg, D.;
- Arnaud, J.-D.;
- Titeux, M.;
- Kremer, E. J.;
- Couderc, B.
Publication type:
Article
Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.
Published in:
Gene Therapy, 2006, v. 13, n. 5, p. 440, doi. 10.1038/sj.gt.3302667
By:
- Malecaze, F.;
- Decha, A.;
- Serre, B.;
- Penary, M.;
- Duboue, M.;
- Berg, D.;
- Levade, T.;
- Lubsen, N. H.;
- Kremer, E. J.;
- Couderc, B.
Publication type:
Article
Nuclear Translocation of Basic Fibroblast Growth Factor<sup>a</sup>.
Published in:
Annals of the New York Academy of Sciences, 1991, v. 638, n. 1, p. 127, doi. 10.1111/j.1749-6632.1991.tb49023.x
By:
- AMALRIC, F.;
- BALDIN, V.;
- BOSC-BIERNE, I.;
- BUGLER, B.;
- COUDERC, B.;
- GUYADER, M.;
- PATRY, V.;
- PRATS, H.;
- ROMAN, A. M.;
- BOUCHE, G.
Publication type:
Article
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model.
Published in:
2010
By:
- Delord, J.-P.;
- Quideau, S.;
- Rochaix, P.;
- Caselles, O.;
- Couderc, B.;
- Hennebelle, I.;
- Courbon, F.;
- Canal, P.;
- Allal, B. C.
Publication type:
journal article
Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.
Published in:
Cancer Gene Therapy, 2009, v. 16, n. 4, p. 329, doi. 10.1038/cgt.2008.88
By:
- Lortal, B;
- Gross, F.;
- Peron, J. M.;
- Pénary, M.;
- Berg, D.;
- Hennebelle, I.;
- Favre, G.;
- Couderc, B.
Publication type:
Article
In vivo restoration of RhoB expression leads to ovarian tumor regression.
Published in:
Cancer Gene Therapy, 2008, v. 15, n. 7, p. 456, doi. 10.1038/cgt.2008.12
By:
- Couderc, B.;
- Pradines, A.;
- Rafii, A.;
- Golzio, M.;
- Deviers, A.;
- Allal, C.;
- Berg, D.;
- Penary, M.;
- Teissie, J.;
- Favre, G.
Publication type:
Article

Found: 7

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

Lens cell targetting for gene therapy of prevention of posterior capsule opacification.

Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.

Nuclear Translocation of Basic Fibroblast Growth Factor<sup>a</sup>.

Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model.

Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.

In vivo restoration of RhoB expression leads to ovarian tumor regression.